ISS Urges Investors to Reject CoreWeave’s $9 Billion Acquisition of Core Scientific

Proxy advisory firm Institutional Shareholder Services (ISS) has advised investors to vote against the proposed $9 billion all-stock merger between artificial intelligence infrastructure company CoreWeave (CRWV.O) and data computing firm Core Scientific (CORZ.O). The shareholder vote is scheduled for October 30.

In its recommendation, ISS said that Core Scientific has shown strong independent performance and can continue to grow without being acquired. The firm noted that the company’s current trajectory suggests it could thrive as a standalone entity.

CoreWeave, which provides cloud infrastructure tailored for AI workloads, first proposed the acquisition in July, offering an implied value of $20.40 per share. However, investor Two Seas Capital quickly announced its opposition to the deal, citing concerns about the sale process, valuation, and the fixed exchange ratio, which leaves Core Scientific shareholders exposed to fluctuations in CoreWeave’s stock price.

Since the announcement, CoreWeave’s shares have declined, reducing the total deal value. Meanwhile, Core Scientific’s stock rose more than 5% in post-market trading on Monday, closing at $18.81, as investors appeared to favor keeping the company independent rather than moving forward with the merger.